Tag: CBT > DEA Rescheduling: Page 10

Cannabis Tax Law

280E: How the Cannabis Industry Got Here

As cannabis businesses brace for potential tax relief should the plant be rescheduled, a look at the origins of IRC Section 280E and why it applies to legal, state-level cannabis companies.

October 18, 2023

Cannabis Rescheduling

Rescheduling Cannabis: Would 1961 Drug Treaty Be a Possible Wrench?

Reclassifying cannabis to a Schedule III drug would put the U.S. in noncompliance with the international treaty Single Convention on Narcotic Drugs, 1961. Will this create a barrier for the U.S. in its scheduling review, and if so, to what extent? Historian James H. Mills weighs in.

October 5, 2023

Cannabis Rescheduling

‘There Will Be Wind in Our Sails’

September 26, 2023

Cannabis Rescheduling

‘Descheduling Would Not Be Utopia’

Shane Pennington of Porter Wright Morris & Arthur addresses some of the biggest questions and concerns surrounding cannabis rescheduling, including the role of the FDA and Big Pharma.

September 26, 2023

Interviews & Opinion

Opinion: HHS Rescheduling Recommendation is 'About Damn Time'

The U.S. Department of Health and Human Services recognition that cannabis should no longer be classified in the same category as heroin is an event to be celebrated. But the trajectory of U.S. policy deserves to be mourned.

September 20, 2023

Cannabis Rescheduling

'Descheduling Would Not Be Utopia'

Shane Pennington of Porter Wright Morris & Arthur addresses some of the biggest questions and concerns surrounding cannabis rescheduling, including the role of the FDA and Big Pharma.

September 13, 2023

Cannabis Industry Research

The Impacts of Cannabis Rescheduling: Panelists Weigh In During International Cannabis Bar Association Webinar

Industry legal experts Khurshid Khoja, Amber Littlejohn and Shane Pennington shared insight into what rescheduling could mean for taxes, research and federal enforcement.

September 12, 2023

Colorado

Colorado Governor to President Biden: ‘We Must Do Better’ on Federal Cannabis Reform

Gov. Jared Polis encouraged the president to move swiftly to reschedule cannabis and urged him to not let up on other incremental changes.

September 5, 2023

Cannabis Rescheduling

‘Rescheduling is Not Enough,’ And Other Reactions to HHS Recommendation on Cannabis

Cannabis industry responds with cautious optimism to the Department of Health and Human Services' call to reschedule the plant, noting the significance of the announcement but also the potential limitations of the move.

September 5, 2023

Cannabis Rescheduling

US Health and Human Services Department Recommends Cannabis Reclassified to Schedule III

The move from Schedule I to Schedule III would provide that cannabis has a federally accepted medical use, but the decision now goes to the DEA.

August 30, 2023

Interviews & Opinion

Opinion: Rescheduling Is Recriminalizing, Descheduling Is Decriminalizing

President of cannabis genetics company DNA Genetics, Rezwan Khan, weighs in on Biden's cannabis policy reform plan and how rescheduling or descheduling the plant would impact the industry.

August 29, 2023

The Last Word

A Unified National Cannabis Policy

FDA’s new senior public health adviser Norman Birenbaum talks about the agency’s approach to hemp-derived products and cannabis regulation, and what may come next.

March 13, 2023